查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387329

慢性腎臟病(CKD) 市場報告：2030 年趨勢、預測與競爭分析

Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

慢性腎臟病(CKD) 趨勢與預測

預計到 2030 年，全球慢性腎臟病(CKD) 市場將達到 836 億美元，2024 年至 2030 年年複合成長率為 6.5%。該市場的主要促進因素是慢性腎臟病（CKD）患者數量的增加以及技術先進的產品和診斷測試的可用性。全球慢性腎臟病（CKD）市場前景廣闊，醫院和透析中心市場蘊藏未來性。

慢性腎臟病(CKD) 市場洞察

Lucintel 預測，在預測期內，藥品的成長將高於新藥和新療法的推出，以幫助醫療專業人員有效治療患者。

在這個市場中，醫院預計將出現高速成長，因為它們配備了 CKD 治療和管理所需的先進設備。

由於大量患者的存在以及對優質醫療保健的需求不斷增加，預計亞太地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球慢性腎臟病（CKD）市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球慢性腎臟病（CKD）市場趨勢（2018-2023）與預測（2024-2030）
  • 按治療分類的全球慢性腎臟病(CKD) 市場
    • 藥品
    • 透析
  • 全球慢性腎臟病(CKD) 市場（依最終用途）
    • 醫院
    • 透析中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球慢性腎臟病（CKD）市場按地區分類
  • 北美慢性腎臟病（CKD）市場
  • 歐洲慢性腎臟病（CKD）市場
  • 亞太地區慢性腎臟病(CKD) 市場
  • 其他地區慢性腎臟病（CKD）市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球慢性腎臟病(CKD) 市場成長機會（按治療）
    • 全球慢性腎臟病(CKD) 市場成長機會（依最終用途）
    • 全球慢性腎臟病(CKD) 市場成長機會（按地區）
  • 全球慢性腎臟病（CKD）市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球慢性腎臟病(CKD) 市場的產能
    • 全球慢性腎臟病(CKD) 市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer
簡介目錄

Chronic Kidney Disease Trends and Forecast

The future of the global chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets. The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.

A more than 150-page report is developed to help in your business decisions.

Chronic Kidney Disease by Segment

The study includes a forecast for the global chronic kidney disease by treatment, end use, and region.

Chronic Kidney Disease Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Drugs
  • Dialysis

Chronic Kidney Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Dialysis Center
  • Others

Chronic Kidney Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Chronic Kidney Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic kidney disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic kidney disease companies profiled in this report include-

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer

Chronic Kidney Disease Market Insights

Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.

Within this market, hospitals is expected to witness the higher growth as it is equipped with advanced facilities, which are required to treat and manage CKD

APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.

Features of the Global Chronic Kidney Disease Market

Market Size Estimates: Chronic kidney disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chronic kidney disease market size by treatment, end use, and region in terms of value ($B).

Regional Analysis: Chronic kidney disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatments, end uses, and regions for the chronic kidney disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic kidney disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the chronic kidney disease market size?

Answer: The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030.

Q2. What is the growth forecast for chronic kidney disease market?

Answer: The global chronic kidney disease market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the chronic kidney disease market?

Answer: The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.

Q4. What are the major segments for chronic kidney disease market?

Answer: The future of the chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets.

Q5. Who are the key chronic kidney disease market companies?

Answer: Some of the key chronic kidney disease companies are as follows:

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer

Q6. Which chronic kidney disease market segment will be the largest in future?

Answer: Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.

Q7. In chronic kidney disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the chronic kidney disease market by treatment (drugs and dialysis), end use (hospital, dialysis center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chronic Kidney Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Chronic Kidney Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Chronic Kidney Disease Market by Treatment
    • 3.3.1: Drugs
    • 3.3.2: Dialysis
  • 3.4: Global Chronic Kidney Disease Market by End Use
    • 3.4.1: Hospital
    • 3.4.2: Dialysis Center
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Chronic Kidney Disease Market by Region
  • 4.2: North American Chronic Kidney Disease Market
    • 4.2.2: North American Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.3: European Chronic Kidney Disease Market
    • 4.3.1: European Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.3.2: European Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.4: APAC Chronic Kidney Disease Market
    • 4.4.1: APAC Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.4.2: APAC Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.5: ROW Chronic Kidney Disease Market
    • 4.5.1: ROW Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.5.2: ROW Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Chronic Kidney Disease Market by Treatment
    • 6.1.2: Growth Opportunities for the Global Chronic Kidney Disease Market by End Use
    • 6.1.3: Growth Opportunities for the Global Chronic Kidney Disease Market by Region
  • 6.2: Emerging Trends in the Global Chronic Kidney Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Chronic Kidney Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Kidney Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Baxter International
  • 7.2: Teva Pharmaceutical Industries
  • 7.3: AstraZeneca
  • 7.4: Johnson & Johnson
  • 7.5: AbbVie
  • 7.6: Becton
  • 7.7: Dickinson and Company
  • 7.8: B. Braun
  • 7.9: F. Hoffmann-La Roche
  • 7.10: Pfizer